Inhibition of the Metabolism of 25-Hydroxycholecalciferol by Actinomycin D and Cycloheximide

AUTOR(ES)

Tanaka, Y.

RESUMO

Actinomycin D (or cycloheximide) administered prior to radioactive 25-hydroxycholecalciferol blocks the metabolism of 25-hydroxycholecalciferol to polar metabolites that accumulate in intestinal tissue, while it does not prevent the 25-hydroxylation of vitamin D3 in the liver. Actinomycin D given after radioactive 25-hydroxycholecalciferol does not inhibit 25-hydroxycholecalciferol metabolism. These results indicate that 25-hydroxycholecalciferol must interact with the nuclei of cells to bring about the production of an enzyme(s) that converts it to its polar metabolites.

Documentos Relacionados

• Control of 25-Hydroxycholecalciferol Metabolism by Parathyroid Glands
• 25-hydroxycholecalciferol stimulation of muscle metabolism.
• Inhibition of Parathyroid Hormone Secretion by 25-Hydroxycholecalciferol and 24,25-Dihydroxycholecalciferol in the Dog
• Effects of Cortisone Administration on the Metabolism and Localization of 25-Hydroxycholecalciferol in the Rat
• Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol